4005.T: Sumitomo Chemical Company, Limited Financials
Sumitomo Chemical Company, Limited Income Statement
Total revenue
Net income
Gross margin TTM
28.7%
Operating margin TTM
4.41%
Net profit margin TTM
2.62%
Return on investment TTM
6.04%
| Period end | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Total revenue | 2,328,515,000,000 | 2,606,281,000,000 | 2,446,893,000,000 | 2,895,283,000,000 |
| Operating income | 102,763,000,000 | 144,085,000,000 | -113,869,000,000 | 47,250,000,000 |
| Net income | 60,947,000,000 | 38,591,000,000 | -311,838,000,000 | 6,987,000,000 |
All line items
| Line item | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Total revenue | 2,328,515,000,000 | 2,606,281,000,000 | 2,446,893,000,000 | 2,895,283,000,000 |
| Cost of revenue | 1,660,247,000,000 | 1,930,487,000,000 | 2,001,116,000,000 | 2,133,164,000,000 |
| Gross profit | 668,268,000,000 | 675,794,000,000 | 445,777,000,000 | 762,119,000,000 |
| Research and development expenses | 0 | 141,734,000,000 | 179,062,000,000 | 191,181,000,000 |
| General and administrative expenses | 0 | 0 | 0 | 0 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 565,505,000,000 | 389,975,000,000 | 380,584,000,000 | 523,688,000,000 |
| Other expenses | 0 | 0 | 0 | 0 |
| Operating expenses | 565,505,000,000 | 531,709,000,000 | 559,646,000,000 | 714,869,000,000 |
| Cost and expenses | 2,225,752,000,000 | 2,462,196,000,000 | 2,560,762,000,000 | 2,848,033,000,000 |
| Net interest income | -35,676,000,000 | -20,975,000,000 | -13,457,000,000 | -11,100,000,000 |
| Interest income | 28,100,000,000 | 10,878,000,000 | 16,734,000,000 | 12,993,000,000 |
| Interest expense | 63,776,000,000 | 31,853,000,000 | 30,191,000,000 | 24,093,000,000 |
| Depreciation and amortization | 121,069,000,000 | 138,551,000,000 | 157,522,000,000 | 167,957,000,000 |
| EBITDA | 300,913,000,000 | 228,497,000,000 | -275,079,000,000 | 192,281,000,000 |
| EBIT | 179,844,000,000 | 89,946,000,000 | -432,601,000,000 | 24,324,000,000 |
| Non-operating income (excl. interest) | -77,081,000,000 | 54,139,000,000 | 318,732,000,000 | 22,926,000,000 |
| Operating income | 102,763,000,000 | 144,085,000,000 | -113,869,000,000 | 47,250,000,000 |
| Total other income/expenses (net) | 13,305,000,000 | -85,992,000,000 | -348,923,000,000 | -47,019,000,000 |
| Income before tax | 116,068,000,000 | 58,093,000,000 | -462,792,000,000 | 231,000,000 |
| Income tax expense | 666,000,000 | 15,405,000,000 | 2,657,000,000 | 47,096,000,000 |
| Net income from continuing operations | 115,402,000,000 | 42,688,000,000 | -465,449,000,000 | -46,865,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 60,947,000,000 | 38,591,000,000 | -311,838,000,000 | 6,987,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 60,947,000,000 | 38,591,000,000 | -311,838,000,000 | 6,987,000,000 |
| EPS | 37 | 24 | -191 | 4 |
| Diluted EPS | 37 | 24 | -191 | 4 |
| Weighted average shares outstanding | 1,640,185,000 | 1,635,928,000 | 1,635,352,000 | 1,634,980,000 |
| Weighted average diluted shares outstanding | 1,640,724,000 | 1,636,515,000 | 1,635,352,000 | 1,635,275,000 |
Sumitomo Chemical Company, Limited Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
910,033,000,000%
Total debt / assets MRQ
—
| Period end | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Total assets | 3,405,041,000,000 | 3,439,784,000,000 | 3,934,818,000,000 | 4,165,503,000,000 |
| Total liabilities | 2,168,368,000,000 | 2,365,369,000,000 | 2,770,452,000,000 | 2,676,314,000,000 |
| Total equity | 1,008,644,000,000 | 900,790,000,000 | 965,753,000,000 | 1,171,192,000,000 |
All line items
| Line item | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Cash and cash equivalents | 208,589,000,000 | 209,838,000,000 | 217,449,000,000 | 305,844,000,000 |
| Short-term investments | 0 | 0 | 0 | 0 |
| Cash and short-term investments | 208,589,000,000 | 209,838,000,000 | 217,449,000,000 | 305,844,000,000 |
| Net receivables | 608,670,000,000 | 593,836,000,000 | 620,022,000,000 | 603,161,000,000 |
| Accounts receivable | 608,670,000,000 | 593,836,000,000 | 620,022,000,000 | 603,161,000,000 |
| Other receivables | 0 | 0 | 0 | 0 |
| Inventory | 595,471,000,000 | 625,243,000,000 | 709,637,000,000 | 744,474,000,000 |
| Prepaid expenses | 0 | 0 | 0 | 0 |
| Other current assets | 94,980,000,000 | 154,217,000,000 | 128,774,000,000 | 109,405,000,000 |
| Total current assets | 1,507,710,000,000 | 1,583,134,000,000 | 1,675,882,000,000 | 1,762,884,000,000 |
| Property, plant and equipment (net) | 770,688,000,000 | 759,266,000,000 | 796,526,000,000 | 829,355,000,000 |
| Goodwill | 275,711,000,000 | 257,811,000,000 | 263,757,000,000 | 266,868,000,000 |
| Intangible assets | 225,334,000,000 | 239,319,000,000 | 272,921,000,000 | 403,996,000,000 |
| Goodwill and intangible assets | 501,045,000,000 | 497,130,000,000 | 536,678,000,000 | 670,864,000,000 |
| Long-term investments | 505,084,000,000 | 465,382,000,000 | 319,988,000,000 | 402,980,000,000 |
| Tax assets | 39,227,000,000 | 34,608,000,000 | 37,070,000,000 | 39,492,000,000 |
| Other non-current assets | 81,287,000,000 | 100,264,000,000 | 568,674,000,000 | 459,928,000,000 |
| Total non-current assets | 1,897,331,000,000 | 1,856,650,000,000 | 2,258,936,000,000 | 2,402,619,000,000 |
| Other assets | 0 | 0 | 0 | 0 |
| Total assets | 3,405,041,000,000 | 3,439,784,000,000 | 3,934,818,000,000 | 4,165,503,000,000 |
| Total payables | 471,444,000,000 | 498,759,000,000 | 551,929,000,000 | 547,637,000,000 |
| Accounts payable | 464,422,000,000 | 488,132,000,000 | 543,384,000,000 | 515,865,000,000 |
| Other payables | 7,022,000,000 | 10,627,000,000 | 8,545,000,000 | 31,772,000,000 |
| Accrued expenses | 0 | 0 | 0 | 0 |
| Short-term debt | 241,422,000,000 | 252,892,000,000 | 585,905,000,000 | 396,903,000,000 |
| Capital lease obligations (current) | 0 | 0 | 0 | 0 |
| Tax payables | 0 | 0 | 8,545,000,000 | 8,545,000,000 |
| Deferred revenue | 0 | 0 | 0 | 0 |
| Other current liabilities | 288,480,000,000 | 287,096,000,000 | 305,653,000,000 | 333,827,000,000 |
| Total current liabilities | 1,001,346,000,000 | 1,038,747,000,000 | 1,443,487,000,000 | 1,278,367,000,000 |
| Long-term debt | 910,033,000,000 | 1,033,236,000,000 | 977,581,000,000 | 1,064,463,000,000 |
| Capital lease obligations (non-current) | 0 | 83,242,000,000 | 91,913,000,000 | 91,914,000,000 |
| Deferred revenue (non-current) | 0 | 0 | 0 | 0 |
| Deferred tax liabilities (non-current) | 78,321,000,000 | 111,048,000,000 | 121,146,000,000 | 101,164,000,000 |
| Other non-current liabilities | 178,668,000,000 | 99,096,000,000 | 136,325,000,000 | 140,406,000,000 |
| Total non-current liabilities | 1,167,022,000,000 | 1,326,622,000,000 | 1,326,965,000,000 | 1,397,947,000,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 0 | 83,242,000,000 | 91,913,000,000 | 91,914,000,000 |
| Total liabilities | 2,168,368,000,000 | 2,365,369,000,000 | 2,770,452,000,000 | 2,676,314,000,000 |
| Treasury stock | -2,650,000,000 | -8,361,000,000 | -8,355,000,000 | -8,349,000,000 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 90,179,000,000 | 90,059,000,000 | 89,938,000,000 | 89,810,000,000 |
| Retained earnings | 655,384,000,000 | 640,611,000,000 | 578,175,000,000 | 891,552,000,000 |
| Additional paid-in capital | 1,966,000,000 | 0 | 237,000,000 | 0 |
| Accumulated other comprehensive income/loss | 263,765,000,000 | 178,481,000,000 | 305,758,000,000 | 198,179,000,000 |
| Other stockholders' equity | 0 | 0 | 0 | 0 |
| Total stockholders' equity | 1,008,644,000,000 | 900,790,000,000 | 965,753,000,000 | 1,171,192,000,000 |
| Total equity | 1,236,673,000,000 | 1,074,415,000,000 | 1,164,366,000,000 | 1,489,189,000,000 |
| Minority interest | 228,029,000,000 | 173,625,000,000 | 198,613,000,000 | 317,997,000,000 |
| Total liabilities and total equity | 3,405,041,000,000 | 3,439,784,000,000 | 3,934,818,000,000 | 4,165,503,000,000 |
| Total investments | 505,084,000,000 | 465,382,000,000 | 319,988,000,000 | 402,980,000,000 |
| Total debt | 1,151,455,000,000 | 1,369,370,000,000 | 1,655,399,000,000 | 1,553,280,000,000 |
| Net debt | 942,866,000,000 | 1,159,532,000,000 | 1,437,950,000,000 | 1,247,436,000,000 |
Sumitomo Chemical Company, Limited Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Cash from operations | 234,759,000,000 | 233,027,000,000 | -51,317,000,000 | 111,621,000,000 |
| Cash from investing | -74,821,000,000 | 79,899,000,000 | -112,240,000,000 | -218,484,000,000 |
| Cash from financing | -199,068,000,000 | -295,448,000,000 | 49,246,000,000 | 20,571,000,000 |
| Net change in cash | -1,249,000,000 | -7,611,000,000 | -88,395,000,000 | -59,585,000,000 |
All line items
| Line item | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Net income | 60,947,000,000 | 38,591,000,000 | -311,838,000,000 | 6,987,000,000 |
| Depreciation and amortization | 121,069,000,000 | 138,551,000,000 | 157,522,000,000 | 167,957,000,000 |
| Deferred income tax | 0 | 0 | 0 | 0 |
| Stock-based compensation | 0 | 0 | 0 | 0 |
| Change in working capital | 15,748,000,000 | 58,481,000,000 | -47,825,000,000 | -124,446,000,000 |
| Accounts receivable | -3,624,000,000 | -21,964,000,000 | 34,798,000,000 | 134,499,000,000 |
| Inventory | 38,564,000,000 | 56,532,000,000 | 78,554,000,000 | -79,887,000,000 |
| Accounts payable | -71,947,000,000 | -6,113,000,000 | -32,251,000,000 | -63,628,000,000 |
| Other working capital | 52,755,000,000 | 30,026,000,000 | -128,926,000,000 | -115,430,000,000 |
| Other non-cash items | 36,995,000,000 | -2,596,000,000 | 150,824,000,000 | 61,123,000,000 |
| Net cash from operating activities | 234,759,000,000 | 233,027,000,000 | -51,317,000,000 | 111,621,000,000 |
| Investments in property, plant and equipment | -121,566,000,000 | -130,465,000,000 | -152,873,000,000 | -143,581,000,000 |
| Acquisitions (net) | 52,969,000,000 | 39,347,000,000 | 21,641,000,000 | -167,924,000,000 |
| Purchases of investments | -128,247,000,000 | -8,175,000,000 | -9,226,000,000 | -7,692,000,000 |
| Sales/maturities of investments | 121,426,000,000 | 179,970,000,000 | 97,963,000,000 | 49,520,000,000 |
| Other investing activities | 597,000,000 | -778,000,000 | -69,745,000,000 | 51,193,000,000 |
| Net cash from investing activities | -74,821,000,000 | 79,899,000,000 | -112,240,000,000 | -218,484,000,000 |
| Net debt issuance | -152,746,000,000 | -262,279,000,000 | 93,271,000,000 | 92,970,000,000 |
| Long-term net debt issuance | -118,319,000,000 | 886,000,000 | 37,866,000,000 | -42,989,000,000 |
| Short-term net debt issuance | -34,427,000,000 | -263,165,000,000 | 55,405,000,000 | 135,959,000,000 |
| Net stock issuance | 0 | 0 | 0 | 0 |
| Net common stock issuance | 0 | 0 | 0 | 0 |
| Common stock issuance | 0 | 0 | 0 | 0 |
| Common stock repurchased | 0 | 0 | 0 | 0 |
| Net preferred stock issuance | 0 | 0 | 0 | 0 |
| Net dividends paid | -19,680,000,000 | -9,866,000,000 | -19,639,000,000 | -42,484,000,000 |
| Common dividends paid | -19,680,000,000 | -9,866,000,000 | -19,639,000,000 | -42,484,000,000 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
| Other financing activities | -26,642,000,000 | -23,303,000,000 | -24,386,000,000 | -29,915,000,000 |
| Net cash from financing activities | -199,068,000,000 | -295,448,000,000 | 49,246,000,000 | 20,571,000,000 |
| Effect of FX changes on cash | 37,881,000,000 | -25,089,000,000 | 25,916,000,000 | 26,707,000,000 |
| Net change in cash | -1,249,000,000 | -7,611,000,000 | -88,395,000,000 | -59,585,000,000 |
| Cash at end of period | 208,589,000,000 | 209,838,000,000 | 217,449,000,000 | 305,844,000,000 |
| Cash at beginning of period | 209,838,000,000 | 217,449,000,000 | 305,844,000,000 | 365,429,000,000 |
| Operating cash flow | 234,759,000,000 | 233,027,000,000 | -51,317,000,000 | 111,621,000,000 |
| Capital expenditure | -121,566,000,000 | -130,465,000,000 | -152,873,000,000 | -143,581,000,000 |
| Free cash flow | 113,193,000,000 | 102,562,000,000 | -204,190,000,000 | -31,960,000,000 |
| Income taxes paid | 0 | 0 | 0 | 0 |
| Interest paid | 0 | 0 | 0 | 0 |